3 New Strong Buy Ratings from Top-Rated Analysts: 10/07/2025

Here’s a peek at the latest picks from our Strong Buy Stocks from Top Wall Street Analysts screener:

• Amphenol (APH) just got a Strong Buy upgrade from a top 1% analyst
• Teva Pharmaceutical Industries (TEVA) ONLY has Strong Buy ratings among the experts we track 
• Borgwarner (BWA) is a top-rated stock in a top-rated industry 

P.S. Get more alerts like this daily … Try WallStreetZen Premium.

A note from our sponsors...

1. Amphenol (NYSE: APH)

Amphenol supplies connectors, cables, and sensors to industries ranging from automotive and aerospace to IT, mobile devices, and industrial equipment. A behind-the-scenes play with exposure to a variety of high-growth sectors, just like our previous entry, APH is set to benefit from strong auto demand. In addition, management and key company personnel seem quite bullish, as they’ve been scooping up shares lately.

Zen Rating: B (Buy) — see full analysis >  

Recent Price: $125.12 — get current quote > 

Max 1-year forecast: $145.00 

Why we’re watching:

• Analyst coverage of Amphenol is overwhelmingly positive — the stock has 5 Strong Buy ratings, 2 Buy ratings, and 2 Hold ratings. See the ratings 
• Mark Delaney of Goldman Sachs (a top 2% rated analyst) recently reiterated a Strong Buy rating on APH shares, and upped his price forecast from $124 to $139.
• Delaney contextualized their price target hike on Amphenol by telling readers that Goldman Sachs raised its FY 2025 U.S. auto forecast from 15.75M to 16.2M and its FY 2026 forecast from 15.5M to 16M vehicles delivered based on "solid YTD sales.
• The analyst explained that their firm's leading indicators analysis implies stronger demand for vehicles, and "relatively benign" pricing actions from the industry in response to tariffs.
• Goldman Sachs reduced its U.S. BEV mix assumptions for FY 2026 and beyond, Delaney added.
• A couple of days before Delaney’s revised coverage, Citigroup’s Asiya Merchant (a top 1% rated analyst) also doubled down on a Strong Buy rating, and hiked her price target from $125 to a Street-high $145.
• In a Connector sector overview note, Merchant said they hiked estimates for the group to account for rising hyperscaler spending and improving margin commentary.
• Connector names should continue to see margin expansion from strong demand for connectivity solutions in AI applications, the analyst detailed.
• APH is currently the 11th highest-rated stock in the Electronic Component industry, which has an Industry Rating of A.
• Amphenol currently ranks in the top 7% of the equities that we track, giving it a Zen Rating of B, which has historically corresponded to an average annual return of 19.88%.
• Our Sentiment Component Grade rating takes into account factors such as earnings surprises, analyst coverage, short interest, and insider action. The last factor is crucial in APH’s case — 50.73% of the insider transactions tied to the stock in the past 12 months have been purchases. In this category, Amphenol ranks in the 96th percentile of stocks.
• However, Momentum, where APH ranks in the top 3%, is the stock’s strongest suit — owing to an 81.32% year-to-date (YTD) gain. (See all 7 Zen Component Grades here >)

2. Teva Pharmaceutical Industries (NYSE: TEVA) 

One of the world’s largest generic drug manufacturers, Teva Pharmaceutical Industries maintains a vast portfolio spanning hundreds of treatments. The company enjoys a dominant position in generics, and currently offers very compelling growth prospects at a very modest valuation.

Zen Rating: A (Strong Buy) — see full analysis >  

Recent Price: $20.05 — get current quote > 

Max 1-year forecast: $26.00 

Why we’re watching:

• Analyst coverage of TEVA is unanimously bullish — the stock currently has 5 Strong Buy ratings: See the ratings 
• The average 12-month price forecast for Teva Pharmaceutical Industries shares is currently pegged at $24, andi implies a hefty 19.64% upside.
• Ashwani Verma of UBS (a top 26% rated analyst) recently maintained a Strong Buy rating on the stock, and increased his price target from $23 to a Street-high $26.
• Verma contextualized their price target on Teva Pharmaceutical Industries by saying that "the stock can continue to see a relief rally until the Austedo IRA price is revealed on or before 2025/011/30.
• Checks with payors imply that the potential IRA discount against list price on Austedo could be 40%, the analyst said.
• TEVA is the 13th highest-rated stock in the Pharmaceutical industry, which has an Industry Rating of B.
• Teva Pharmaceutical Industries ranks in the 95th percentile of the stocks that we track, giving the stock a Zen Rating of A.
• TEVA offers a rare blend of Value and Growth — in both categories, the stock ranks in the top 10% of equities.
• However, Teva Pharmaceutical Industries ranks even higher in terms of Safety — in the top 7% of stocks, to be precise (See all 7 Zen Component Grades here >)

3. Borgwarner (NYSE: BWA) 

This past Stock of the Week selection is a global auto parts supplier best known for its powertrain and drivetrain technologies. The company services virtually every major automaker and has been engaged in a strong pivot toward electrification. Major Wall Street firms are expecting favorable conditions for the industry, and BWA, currently trading at a discount, is poised to benefit.

Zen Rating: A (Strong Buy) — see full analysis >  

Recent Price: $44.11 — get current quote > 

Max 1-year forecast: $54.00 

Why we’re watching:

• Borgwarner enjoys broad, bullish support from Wall Street analysts. The stock currently has 8 Strong Buy ratings, 2 Buy ratings, and 3 Hold ratings. See the ratings 
• Goldman Sachs equity researcher Kash Rangan (a top 12% rated analyst) recently maintained a Strong Buy rating on BWA, and increased his price target from $45 to $52.
• Rangan contextualized their price target hike on BorgWarner by telling readers that Goldman Sachs raised its FY 2025 U.S. auto forecast from 15.75M to 16.2M and its FY 2026 forecast from 15.5M to 16M vehicles delivered based on "solid YTD sales.
• The analyst explained that their firm's leading indicators analysis implies stronger demand for vehicles, and "relatively benign" pricing actions from the industry in response to tariffs.
• Goldman Sachs reduced its U.S. BEV mix assumptions for FY 2026 and beyond, Rangan added.
• BWA is the 6th highest-rated stock in the Auto Part industry, which has an Industry Rating of A.
• Our quant rating system, Zen Ratings, uses 115 proprietary factors to evaluate roughly 4,600 stocks each day. Stocks that rank in the top 5% are given a Zen Rating of A, and have provided an average annual return of 32.52% since the early 2000s. At present, Borgwarner ranks in the top 2% of stocks.
• Each Zen Rating is a composite of 7 Component Grade ratings, all of which focus on specific areas. For example, BWA is currently trading at an attractive price to earnings growth (PEG) ratio of 0.4x, and ranks in the top 16% of equities in terms of Value.
• BWA also ranks in the 87th and 89th percentile when it comes to Safety and Financials, respectively
• However, Borgwarner’s strongest suit is its Artificial Intelligence Component Grade rating. It is derived from the findings of a neural network trained on more than two decades of market data, which is used to identify likely outperformers. In this category, BWA ranks in the top 3% of stocks. (See all 7 Zen Component Grades here >)

What to Do Next?

• 77 Best Stocks NOW! >
• See All “A” Rated Stocks with +32.52% Average Annual Return >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.